Immunoadsorption for systemic lupus erythematosus

Atherosclerosis Supplements

Volumn 10, Issue 5, 2009, Pages 110-113

  Stummvoll, G H ^a   Julius, U ^b   Derfler, K ^a   Aringer, M ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Aheresis; Immunoadsorption; Pregnancy; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DEXTRAN SULFATE; DOUBLE STRANDED DNA ANTIBODY; GLUCOCORTICOID; IMMUNOGLOBULIN G; PROTEIN A; RITUXIMAB;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; DISEASE SEVERITY; HUMAN; IMMUNOADSORPTION; NEPHROTIC SYNDROME; OFF LABEL DRUG USE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE;

ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; BIOLOGICAL PRODUCTS; BLOOD COMPONENT REMOVAL; FEMALE; HUMANS; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 72649093185     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5688(09)71823-9     Document Type: Article

References (32)

1. Cervera R., Bucciarelli S., Plasin M.A., Gomez-Puerta J.A., Plaza J., Pons-Estel G., et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". J Autoimmun 32 3-4 (2009) 240-245
2. Wilson H.A., Winfield J.B., Lahita R.G., and Koffler D. Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus. Arthritis Rheum 22 5 (1979) 458-462
3. Sultan S.M., Begum S., and Isenberg D.A. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. Rheumatology (Oxford) 42 2 (2003) 230-234
4. Wener M.H. Immune complexes in systemic lupus erythematosus. In: Tsokos G.C., Gordon C., and Smolen J.S. (Eds). Systemic lupus erythe matosus. 1 ed. (2007), Mosby, Philadelphia 214-224
5. Todd D.J., and Costenbader K.H. Dyspnoea in a young woman with active systemic lupus erythematosus. Lupus 18 9 (2009) 777-784
6. Carmier D., Marchand-Adam S., Diot P., and Diot E. [Respiratory involvement in systemic lupus erythematosus]. Rev Mal Respir 25 10 (2008) 1289-1303
7. Lewis E.J. Plasmapheresis therapy is ineffective in SLE. Lupus Nephritis Collaborative Study Group. J Clin Apheresis 7 3 (1992) 153
8. Doria A., Piccoli A., Vesco P., Vaccaro E., Marson P., De S.G., et al. Therapy of lupus nephritis. A two-year prospective study. Ann Med Interne (Paris) 145 5 (1994) 307-311
9. Euler H.H., Schroeder J.O., Harten P., Zeuner R.A., and Gutschmidt H.J. Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum 37 12 (1994) 1784-1794
10. Wallace D.J., Goldfinger D., Pepkowitz S.H., Fichman M., Metzger A.L., Schroeder J.O., et al. Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis. J Clin Apheresis 13 4 (1998) 163-166
11. Aringer M., Smolen J.S., and Graninger W.B. Severe infections in plasma- pheresis-treated systemic lupus erythematosus. Arthritis Rheum 41 3 (1998) 414-420
12. Stummvoll G.H., Aringer M., Jansen M., Smolen J.S., Derfler K., and Graninger W.B. Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacy. Wien Klin Wochenschr 116 21-22 (2004) 716-724
13. Dittrich E., Schmaldienst S., Langer M., Jansen M., Horl W.H., and Derfler K. Immunoadsorption and plasma exchange in pregnancy. Kidney Blood Press Res 25 4 (2002) 232-239
14. Schmaldienst S., Jansen M., Hollenstein U., Graninger W., Regele H., Horl W.H., et al. Treatment of systemic lupus erythematosus by immuno adsorption in a patient suffering from tuberculosis. Am J Kidney Dis 39 2 (2002) 415-418
15. Stummvoll G.H., Aringer M., Smolen J.S., Schmaldienst S., Jimenez-Boj E., Horl W.H., et al. IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study. Ann Rheum Dis 64 7 (2005) 1015-1021
16. Merrill J.T., Neuwelt C.M., Wallace D.J., Shanahan J.C., Latinis K.M., et al. L12 Efficacy and Safety of Rituximab in Patients with Moderately to Severely Active Systemic Lupus Erythematosus (SLE): Results from the Randomized, Double-blind Phase II/IIIStudy EXPLORER. Arthritis Rheum 58 9 (Supplement) (2008) Ref Type: Abstract
17. Lu T.Y., Ng K.P., Cambridge G., Leandro M.J., Edwards J.C., Ehrenstein M., et al. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients. Arthritis Rheum 61 4 (2009) 482-487
18. Aringer M., Graninger W.B., Steiner G., and Smolen J.S. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study. Arthritis Rheum 50 10 (2004) 3161-3169
19. Schmaldienst S., Mullner M., Goldammer A., Spitzauer S., Banyai S., Horl W.H., et al. Intravenous immunoglobulin application following immuno adsorption: benefit or risk in patients with autoimmune diseases?. Rheumatology (Oxford) 40 5 (2001) 513-521
20. Lhotta K., Wurzner R., Rosenkranz A.R., Beer R., Rudisch A., Neumair F., et al. Cerebral vasculitis in a patient with hereditary complete C4 deficiency and systemic lupus erythematosus. Lupus 13 2 (2004) 139-141
21. Gaubitz M., Seidel M., Kummer S., Schotte H., Perniok A., Domschke W., et al. Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus. J Autoimmun 11 5 (1998) 495-501
22. Braun N., Erley C., Klein R., Kotter I., Saal J., and Risler T. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus. Nephrol Dial Transplant 15 9 (2000) 1367-1372
23. Palmer A., Cairns T., Dische F., Gluck G., Gjorstrup P., Parsons V., et al. Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide. Nephrol Dial Transplant 6 8 (1991) 536-542
24. Rech J., Hueber A.J., Kallert S., Requadt C., Kalden J.R., and Schulze-Koops H. Immunoadsorption and CD20 antibody treatment in a patient with treatment resistant systemic lupus erythematosus and preterminal renal insufficiency. Ann Rheum Dis 65 4 (2006) 552-553
25. Stefanutti C., Vivenzio A., Di G.S., Mareri M., Ceccarelli F., and Valesini G. Cyclophosphamide and immunoadsorption apheresis treatment of lupus nephritis nonresponsive to drug therapy alone. BioDrugs 19 2 (2005) 129-133
26. Braun N., Junger M., Klein R., Gutenberger S., Guagnin M., and Risler T. Dextran sulfate (Selesorb) plasma apheresis improves vascular changes in systemic lupus erythematosus. Ther Apher 6 6 (2002) 471-477
27. Suzuki K. The role of immunoadsorption using dextran-sulfate cellulose columns in the treatment of systemic lupus erythematosus. Ther Apher 4 3 (2000) 239-243
28. Suzuki K., Hara M., Harigai M., Ishizuka T., Hirose T., Matsuki Y., et al. Continuous removal of anti-DNA antibody, using a new extracorporeal immunoadsorption system, in patients with systemic lupus erythematosus. Arthritis Rheum 34 12 (1991) 1546-1552
29. Hashimoto H., Tsuda H., Kanai Y., Kobayashi S., Hirose S., Shinoura H., et al. Selective removal of anti-DNA and anticardiolipin antibodies by adsorbent plasmapheresis using dextran sulfate columns in patients with systemic lupus erythematosus. J Rheumatol 18 4 (1991) 545-551
30. Takahashi S., Wada N., and Harada K. Immunoadsorbent apheresis eliminates pathogenic IgG in childhood lupus nephritis. Pediatr Int 49 6 (2007) 817-821
31. Sugimoto K., Yamaji K., Yang K.S., Kanai Y., Tsuda H., and Hashimoto H. Immunoadsorption plasmapheresis using a phenylalanine column as an effective treatment for lupus nephritis. Ther Apher Dial 10 2 (2006) 187-192
32. Schneider M., Berning T., Waldendorf M., Glaser J., and Gerlach U. Immuno adsorbent plasma perfusion in patients with systemic lupus erythematosus. J Rheumatol 17 7 (1990) 900-907